Summary:
- Intensity Therapeutics, Inc. (INTS) is a biopharmaceutical company that focuses on developing novel cancer therapies.
- The article discusses a significant 21% drop in the company's stock price during pre-market trading, likely due to some recent development or news related to the company's operations or pipeline.
- Fluctuations in the stock price of a biotech company like Intensity Therapeutics can be influenced by various factors, such as clinical trial results, regulatory approvals, or updates on their research and development efforts.